Abbott has filed a complaint to terminate its proposed acquisition of Alere due to Alere's significant loss in value since the January merger agreement.
AveXis Inc., a Bannockburn-based gene therapy company developing treatments for patients with rare and life-threatening neurological genetic diseases, recently named Daniel Welch, Terrence Kearney and Frank Verwiel to its board of directors.
Supporting Strategies - Chicago Far West Suburbs has earned accreditation from the Better Business Bureau (BBB).
Dow AgroSciences LLC announced Monday that it has opened a facility in the Research Park at the University of Illinois at Urbana-Champaign.
Chicago-based Avexis Inc., a company dedicated to the development of treatments for life-threatening neurological diseases, recently made some leadership changes.